Trials / Completed
CompletedNCT02451657
Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome
A Multicenter, Longitudinal, Non-drug Study to Assess the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 6 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the suitability of selected scales (floor/ceiling effects, variability, test-retest reliability) to measure cognitive function in children with Down syndrome over 6 months, and to evaluate the influence of covariates such as age, gender or language on these neurocognitive scales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No intervention was administered in this study |
Timeline
- Start date
- 2015-06-02
- Primary completion
- 2016-06-30
- Completion
- 2016-06-30
- First posted
- 2015-05-22
- Last updated
- 2017-10-25
Locations
10 sites across 3 countries: United States, France, Spain
Source: ClinicalTrials.gov record NCT02451657. Inclusion in this directory is not an endorsement.